Clinical and Laboratory Features of Mycobacterium porcinum
暂无分享,去创建一个
A. Steigerwalt | R. Wallace, | Yansheng Zhang | Rebecca W. Wilson | L. Mann | L. Hall | G. Roberts | A. Kabani | M. Tsukamura | C. Turenne | K. Jost | B. Brown-Elliott | Z. Blacklock | V. Silcox | June M. Brown | C. Crist | M. F. Schinsky | R. Wallace | Christopher J. Crist | R. Wilson
[1] G. Chamoiseau. Etiology of farcy in African bovines: nomenclature of the causal organisms Mycobacterium farcinogenes Chamoiseau and Mycobacterium senegalense (Chamoiseau) comb. nov , 1979 .
[2] L. Hall,et al. Evaluation of the MicroSeq System for Identification of Mycobacteria by 16S Ribosomal DNA Sequencing and Its Integration into a Routine Clinical Mycobacteriology Laboratory , 2003, Journal of Clinical Microbiology.
[3] R. Wallace,,et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. , 1991, The Journal of infectious diseases.
[4] M. Tsukamura,et al. Mycobacterium porcinum sp. nov., a Porcine Pathogen , 1983 .
[5] E. Böttger,et al. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. , 1995, International journal of systematic bacteriology.
[6] J. Musser,et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. , 1989, The Journal of infectious diseases.
[7] R. Wallace,,et al. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. , 1983, Annals of internal medicine.
[8] R. Wallace,,et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms , 1992, Antimicrobial Agents and Chemotherapy.
[9] R. Wallace,,et al. Clinical and Laboratory Features of Mycobacterium mageritense , 2002, Journal of Clinical Microbiology.
[10] Kenneth,et al. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. , 1999, International journal of systematic bacteriology.
[11] J. Musser,et al. Sequence-Based Identification ofMycobacterium Species Using the MicroSeq 500 16S rDNA Bacterial Identification System , 2000, Journal of Clinical Microbiology.
[12] A. Steigerwalt,et al. Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. , 2000, International journal of systematic and evolutionary microbiology.
[13] R. Wallace,,et al. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria , 1995, Journal of clinical microbiology.
[14] A. Steigerwalt,et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical , 2004, International journal of systematic and evolutionary microbiology.
[15] R. Wallace,,et al. Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria. , 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[16] R. Wallace,,et al. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance. , 1985, The American review of respiratory disease.
[17] Henry D. Isenberg,et al. Clinical Microbiology Procedures Handbook , 2004 .
[18] R. Wallace,,et al. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. , 1989, The Journal of infectious diseases.
[19] J. Wolfe,et al. Necessity of Quality-Controlled 16S rRNA Gene Sequence Databases: Identifying Nontuberculous Mycobacterium Species , 2002, Journal of Clinical Microbiology.
[20] M. Goodfellow,et al. Numerical classification of Mycobacterium farcinogenes, Mycobacterium senegalense and related taxa. , 1983, Journal of general microbiology.
[21] W. Baine,et al. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. , 1983, The Journal of infectious diseases.
[22] Frank,et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis , 1993, Journal of clinical microbiology.
[23] C. Thornsberry,et al. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution , 1982, Antimicrobial Agents and Chemotherapy.
[24] R. Good,et al. Identification of clinically significant Mycobacterium fortuitum complex isolates , 1981, Journal of clinical microbiology.
[25] E. Böttger,et al. Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification , 1992, Journal of clinical microbiology.
[26] R. Wallace,,et al. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. , 2001, International journal of systematic and evolutionary microbiology.
[27] T. Bull,et al. Mycobacterium mageritense sp. nov. , 1997, International journal of systematic bacteriology.
[28] J. Albertson,et al. Identification of mycobacteria. , 1967, Military medicine.